Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer

NCT01739634 is registered in ClinicalTrials.gov with Salient Pharmaceuticals Incorporated as lead sponsor.

NCT NCT01739634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01739634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
Lead sponsor
Salient Pharmaceuticals Incorporated
Phase
Phase 1/2
Overall status
Unknown status
Start date
November 30, 2012
Completion date
December 31, 2013
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea, medullary thyroid cancer